JW Asset Management

JW Asset Management is a registered investment adviser based in New York, founded in 1998. The firm specializes in managing hedge funds and private equity funds, with a primary focus on investments in the healthcare sector, alongside interests in pharmaceuticals, agtech, banking, cannabis, consumer products, retail, and wellness. JW Asset Management employs various investment strategies, including sector-oriented equity and event-driven approaches, while maintaining exposure to equities, derivatives, and both corporate and sovereign fixed income. The firm has demonstrated its capabilities through significant investments, such as leading the acquisition of Arbor Pharmaceuticals and serving as the lead investor in TerrAscend Corp.

Jason Klarreich

Executive Vice President and CFO

22 past transactions

Tyson 2.0

Series A in 2022
Tyson 2.0 is a cannabis company founded by the renowned boxer and entrepreneur Mike Tyson. The company specializes in producing a diverse range of cannabis products, including full-spectrum cannabis flowers, concentrates, and consumables. With a commitment to purity and precision, Tyson 2.0 aims to provide consumers with high-quality products that are both premium and affordable. These offerings are widely accessible at retailers across the nation, ensuring that a broad audience can enjoy their products.

Allumia

Series A in 2022
Allumia, LLC specializes in energy efficiency solutions, focusing on lighting upgrades for commercial, athletic, automotive, and industrial sectors. Founded in 2013 and headquartered in Seattle, Washington, with additional offices in Los Angeles and Durham, the company designs, funds, installs, and manages lighting projects. Allumia evaluates existing lighting systems and provides tailored proposals that include updated designs and anticipated savings. The company also supplies replacement lamps, drivers, and other lighting hardware, along with ongoing maintenance services. Utilizing a software and Internet of Things platform, Allumia streamlines the financing and management of energy efficiency projects, enabling clients to achieve complete equipment upgrades at reduced costs while maximizing energy savings. The company serves customers directly and collaborates with utility partners to enhance the efficiency of their operations across the nation.

Pistil Data

Seed Round in 2021
Pistil Data is a prominent market intelligence company specializing in the consumer packaged goods (CPG) sector, particularly within the cannabis industry. The company has developed a comprehensive platform that provides detailed insights into every brand and product in the cannabis market. This platform allows users to identify retail opportunities, track significant market changes, and discover strategies to enhance shelf space for cannabis products. By offering customized sales opportunities and access to crucial data, Pistil Data enables cannabis brands to effectively grow their sales and expand their market presence.

Semasio

Series C in 2021
Semasio GmbH, founded in November 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to assist marketers in profiling and targeting internet users effectively. Its offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, which utilize Natural Language Processing to analyze website content and create detailed user profiles. This enables clients, including global agency networks and advertisers, to identify specific target audiences and optimize their advertising strategies. Semasio's platform supports real-time advertising and provides tools for managing data ownership and transparency. With additional development centers in Denmark and Portugal, Semasio aims to enhance advertising efficiency while adhering to privacy standards.

Cityrow Go

Series A in 2021
Cityrow Go is a rowing-based fitness app for smartphones or tablets. It offers rowing classes programmed to deliver an effective, efficient, and motivating workout to the at-home user.

Semasio

Series B in 2021
Semasio GmbH, founded in November 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to assist marketers in profiling and targeting internet users effectively. Its offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, which utilize Natural Language Processing to analyze website content and create detailed user profiles. This enables clients, including global agency networks and advertisers, to identify specific target audiences and optimize their advertising strategies. Semasio's platform supports real-time advertising and provides tools for managing data ownership and transparency. With additional development centers in Denmark and Portugal, Semasio aims to enhance advertising efficiency while adhering to privacy standards.

Gage Cannabis

Venture Round in 2020
Gage Cannabis Co. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market.

Semasio

Series A in 2020
Semasio GmbH, founded in November 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to assist marketers in profiling and targeting internet users effectively. Its offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, which utilize Natural Language Processing to analyze website content and create detailed user profiles. This enables clients, including global agency networks and advertisers, to identify specific target audiences and optimize their advertising strategies. Semasio's platform supports real-time advertising and provides tools for managing data ownership and transparency. With additional development centers in Denmark and Portugal, Semasio aims to enhance advertising efficiency while adhering to privacy standards.

High 12

Series A in 2019
A brand is not simply a name. It is not just a logo or a website. A brand is an identifier of the larger community in which it resides. We build brands that bring people together, mark a common bond, and thread through the ties of shared social fabric.

Semasio

Seed Round in 2019
Semasio GmbH, founded in November 2010 and headquartered in Hamburg, Germany, specializes in user intelligence and targeting solutions for digital advertising. The company leverages statistical modeling and machine learning to assist marketers in profiling and targeting internet users effectively. Its offerings include Audience Targeting, Contextual Targeting, and Brand Fit Targeting, which utilize Natural Language Processing to analyze website content and create detailed user profiles. This enables clients, including global agency networks and advertisers, to identify specific target audiences and optimize their advertising strategies. Semasio's platform supports real-time advertising and provides tools for managing data ownership and transparency. With additional development centers in Denmark and Portugal, Semasio aims to enhance advertising efficiency while adhering to privacy standards.

Henry's Original

Series B in 2019
Henry's Originals is a producer of handcrafted cannabis products from family-run farms in Mendocino County. Since launching in mid-2017, Henry’s Original has been featured in the Los Angeles Times, Mashable, SF Gate, Men’s Journal, LA Weekly, and Metro.

GrowGeneration

Post in 2019
GrowGeneration is a private company that specializes in the operation of hydroponic and organic gardening retail stores. The company focuses on capitalizing on the growing demand for home gardening and the legalization of marijuana. It serves as a marketer and distributor of a wide range of products essential for hydroponic gardening, including nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems, and various accessories. GrowGeneration operates through two main segments: the Cultivation and Gardening segment, which encompasses its hydroponic and organic gardening business, and the Storage Solutions segment, which includes its offerings in benching, racking, and storage solutions.

Vitruvias Therapeutics

Series A in 2018
Vitruvias Therapeutics is a start-up generic pharmaceutical company that will focus on developing niche topical generic products that are sold only by prescription. The name of the company is taken from Leonardo da Vinci’s drawing “The Vitruvian Man” which refers to the idealized proportionality of the human figure. The company was founded in 2013 and is based in Montgomery, Alabama.

TerrAscend

Post in 2017
TerrAscend Corp. is a Canadian cannabis company that cultivates, processes, and sells both medical and adult-use cannabis in Canada, the United States, and Europe. Founded in 2017 and headquartered in Mississauga, the company emphasizes a vertically-integrated approach, ensuring quality in its product offerings. TerrAscend operates retail dispensaries in California and Pennsylvania, and it also produces hemp-derived wellness products and cannabis-infused artisan edibles. The company offers support and education programs for patients and physicians through its subsidiaries, Solace Health Inc. and Terra Health Network Inc., which provide clinical support and consultations for medical cannabis. Additionally, TerrAscend focuses on drug research and development, as well as innovative cannabis delivery systems, to meet the diverse needs of its patient base.

Vensun Pharmaceuticals

Series C in 2016
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Founded in 2011, the company is focused on co-developing these products through strategic partnerships both domestically and internationally. Vensun has filed multiple Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. The company is also pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions to further enhance its development portfolio, aiming to provide enhanced pharmaceuticals to clinicians and healthcare professionals in the U.S. generic market.

Establishment Labs

Debt Financing in 2016
Establishment Labs S.A. is a medical technology company based in Alajuela, Costa Rica, that specializes in the design, development, manufacturing, and marketing of silicone-filled breast and body shaping implants. The company's flagship product line, Motiva Implants, features a variety of options in surface, shape, size, base, and projection and is sold in over 60 countries. Establishment Labs also offers innovative solutions such as the MotivaImagine application, which aids in surgical planning, and Q Inside Safety Technology, a radio frequency identification transponder that provides surgeons with implant-specific data. Additionally, the company provides Puregraft technology for purified fat reinjection and operates a center for breast augmentation consultations. Its manufacturing facilities comply with FDA and ISO standards, and the company has regulatory offices in the United States and a distribution center in Belgium. Established in 2004, Establishment Labs serves plastic surgeons and patients globally, emphasizing innovation in its product offerings.

Establishment Labs

Venture Round in 2015
Establishment Labs S.A. is a medical technology company based in Alajuela, Costa Rica, that specializes in the design, development, manufacturing, and marketing of silicone-filled breast and body shaping implants. The company's flagship product line, Motiva Implants, features a variety of options in surface, shape, size, base, and projection and is sold in over 60 countries. Establishment Labs also offers innovative solutions such as the MotivaImagine application, which aids in surgical planning, and Q Inside Safety Technology, a radio frequency identification transponder that provides surgeons with implant-specific data. Additionally, the company provides Puregraft technology for purified fat reinjection and operates a center for breast augmentation consultations. Its manufacturing facilities comply with FDA and ISO standards, and the company has regulatory offices in the United States and a distribution center in Belgium. Established in 2004, Establishment Labs serves plastic surgeons and patients globally, emphasizing innovation in its product offerings.

Aralez Pharmaceuticals

Post in 2015
Aralez Pharmaceuticals operates as a pharmaceutical company. The Company focuses on acquiring, developing, and commercializing products primarily in cardiovascular, pain, and other specialty areas. Aralez Pharmaceuticals serves customers worldwide.

Vensun Pharmaceuticals

Series B in 2013
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Founded in 2011, the company is focused on co-developing these products through strategic partnerships both domestically and internationally. Vensun has filed multiple Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. The company is also pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions to further enhance its development portfolio, aiming to provide enhanced pharmaceuticals to clinicians and healthcare professionals in the U.S. generic market.

Vensun Pharmaceuticals

Series A in 2012
Vensun Pharmaceuticals, Inc. is a pharmaceutical company based in Yardley, Pennsylvania, that specializes in developing a diverse portfolio of generic prescription products across various dosage forms and therapeutic categories. Founded in 2011, the company is focused on co-developing these products through strategic partnerships both domestically and internationally. Vensun has filed multiple Abbreviated New Drug Applications (ANDAs) with the FDA and currently has over 30 products in active development. The company is also pursuing additional opportunities for partnerships, strategic alliances, and product acquisitions to further enhance its development portfolio, aiming to provide enhanced pharmaceuticals to clinicians and healthcare professionals in the U.S. generic market.

Arbor Pharmaceuticals

Series B in 2010
Arbor Pharmaceuticals, operates as a specialty pharmaceutical company focusing on pediatric medicine. It engages in licensing, developing, and commercializing late-stage products for common pediatric conditions. The company's products include ZINOTIC and ZINOTIC ES, which addresses Acute Otitis Externa; NEOTIC, an otic analgesic agent for the treatment of pain and inflammation associated with Acute Otitis Media; and XYLAREX for the dietary management of Recurrent Acute Otitis Media. Its products also include Pediaderm HC Complete Kit, which is specifically developed to treat, manage, and protect the skin of children with atopic dermatitis, commonly referred to as eczema. The company markets its products specialty sales forces in the United States. Arbor Pharmaceuticals, was founded in 2006 and is based in Raleigh, North Carolina.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.